Key players in Gene Editing
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 | CRISPR Therapeutics | — | 66 reports |
| 2 | Vertex Pharmaceuticals | — | 264 reports |
| 3 | Intellia Therapeutics | — | 33 reports |
| 4 | Beam Therapeutics | — | 33 reports |
| 5 | Editas Medicine | — | 33 reports |
| 6 | Verve Therapeutics | — | 33 reports |
Also active in Gene Editing
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
| HuidaGene Therapeutics Co., Ltd. |
|
| Caribou Biosciences |
|
| YolTech Therapeutics Co., Ltd |
|
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Top trial sponsors in Gene Editing
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
- CRISPR Therapeutics 6 active trials on ClinicalTrials.gov (opens in a new tab)
- HuidaGene Therapeutics Co., Ltd. 4 active trials on ClinicalTrials.gov (opens in a new tab)
- Intellia Therapeutics 2 active trials on ClinicalTrials.gov (opens in a new tab)
- Editas Medicine 2 active trials on ClinicalTrials.gov (opens in a new tab)
- Caribou Biosciences 2 active trials on ClinicalTrials.gov (opens in a new tab)
- YolTech Therapeutics Co., Ltd 2 active trials on ClinicalTrials.gov (opens in a new tab)
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Gene Editing reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Gene Editing report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.